GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cawachi 2664.T · JPY

Consumer Staples · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

4,145

+1.72%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Cawachi

Its shares trade on Tokyo Stock Exchange under the ticker 2664.T. It has been listed since 1 September 2000. In the fiscal year to 31 March 2026, it reported revenue of ¥284.49bn and net income of ¥3.20bn. At that date it held total assets of ¥199.61bn and shareholders' equity of ¥115.93bn.

Cawachi Ltd. engages in the operation and management of drug stores. The company is headquartered in Oyama-Shi, Tochigi-Ken. The company went IPO on 2000-09-01. The firm sells pharmaceutical products, including cold medicines, digestive medicines, various vitamin tablets, eye drops and nursing care items; cosmetics, including basic skin care products, makeup products and cosmetics for men; miscellaneous goods, including detergents, toilet papers, pet items and milk powders, as well as food products, including processed food products, dairy products, confectioneries, beverages and alcohol through its drugstores.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
1 Sept 2000
Employees
2,770

Leadership

Pay as last reported

  • Mr. Shinji KawachiPresident, Representative Director, since 1991¥161.0m
  • Mr. Hiroshi AsukeExecutive Officer, Director of Administration
  • Mr. Katsuyuki OhkuboDirector of Store Development, President of Subsidiary, Director, since 2013
  • Ms. Miho EtoIndependent Director
  • Mr. Rinji WatanabeIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Operates drug stores in Japan with a focus on pharmaceuticals and retail products
  • Employs 2,770 full-time employees supporting operations
  • Has a long-standing presence since IPO in 2000

Weaknesses

  • Relies solely on drug store operations without diversification mentioned
  • No information provided on digital or online presence
  • Limited product range details beyond listed categories

Opportunities

  • Expansion into e-commerce for pharmaceutical and retail products
  • Potential growth in aging population healthcare needs
  • Increasing demand for health and wellness products in Japan

Threats

  • Competition from larger retail chains in the drug store sector
  • Regulatory changes affecting pharmaceutical sales
  • Economic downturns impacting consumer spending on non-essential items

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.